Oricell Therapeutics
PrivateLast Round
Growth Equity
Apr 9, 2026
Total Funding Raised
$305.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oricell Therapeutics is a biotechnology company that develops innovative and affordable immunotherapies for unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oricell Therapeutics Comparables
Compare Oricell Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbelZeta Pharma | 87% | |
| Beijing Yimiao Shenzhou Pharmaceutical Technology | 87% | |
| TCRCure Biopharma | 86% | |
Oricell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Apr 9, 2026 | ||||
| Series C | Jan 12, 2026 | ||||
| Series B Extension | Feb 28, 2023 | ||||
| Series B | Aug 1, 2022 | ||||
| Early Funding | Dec 1, 2019 | ||||
Angel | Feb 1, 2015 |
Oricell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing E-Town International Investment & Development Co., Ltd. | Series C, Growth Equity |
| 健壹资本 | Series B |
| Boquan Equity Investment Management | Series B |
| Xiamen C&D Emerging Industry Equity Investment | Series B Extension |
| Talon Capital | Series C |
| Elēkrŏn Ventures | Series C, Growth Equity |
| NGS Super | Series C, Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Developing secreted, rapid-production, and in vivo CAR-T approaches.
- Apr 9, 2026
$40M round led by Vivo Capital and Qiming Venture Partners.
Oricell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oricell Therapeutics's valuation, stock price, and market status.